The role of poison exons in neurodevelopment
The role of poison exons in neurodevelopment
批准号:
10373264
负责人:
Gemma Louise Carvill
金额:
$44.0万
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
已结题
起止时间:
2021-09-15 至 2024-03-14
关键词:
Alternative SplicingBiological AssayBrainCell CycleCell LineCell ProliferationCellsComplementCortical MalformationCoupledCycloheximideDNADataDeoxyuridineDevelopmentDiseaseEctopic ExpressionElementsEpilepsyExcisionExonsFundingFutureGene ExpressionGenesGenomeGuide RNAHumanHuman DevelopmentIndividualIntegral Membrane ProteinIon TransportIonsLeadLibrariesMitosisMitoticModelingMusNatureNeurodevelopmental DisorderNeuronal DifferentiationNeuronsNonsense-Mediated DecayOutcome StudyPoisonProductionProtein IsoformsProteinsRNA SplicingResearch ProposalsRoleSynaptic VesiclesTechnologyTerminator CodonTestingTranscriptbasecell motilitycell typecourse developmentdesignexcitatory neurongenetic analysisgenetic variantgenome sequencinghigh rewardhigh riskhigh throughput screeninginduced pluripotent stem cellinhibitor/antagonistnerve stem cellnervous system disorderneurodevelopmentneurogeneticsneuron developmentneuron lossneuropsychiatric disordernovelprematureprogenitorprogramstranscriptome sequencingvesicular release
中文摘要
项目摘要
基因组中导致引入过早截短(终止)密码子(PTC)并标记这些
作为无义介导的衰变(NMD)的靶的转录物被称为毒物外显子(PE)。这些PE具有
最近被证明在小鼠和人类神经发育中使用,
在发展过程中拼接而成。此外,干扰PE剪接的遗传变异已经被发现。
与神经发育障碍相关,包括癫痫和皮质发育畸形。
然而,在整个人类发育过程中选择性剪接的PE的完整补充并不
知道的因此,在本研究的目的1中,我们将在诱导多能干细胞中使用长读段测序,
用放线菌酮处理以抑制NMD的iPSC衍生的神经元祖细胞(NPC)和神经元,
识别PE。此外,虽然最近的努力已经阐明了PE在神经发育过程中的作用,但我们
对其功能的了解非常有限。在目标2中,我们将调整最近描述的成对引导RNA
选择性外显子去除(pgFARM)方法删除iPSC衍生的神经元祖细胞中的候选PE
细胞(NPC),并确定对这些细胞增殖的影响。我们的初步分析表明,
许多包含在NPC转录物中的PE(NPC-PE)编码成熟神经元生长所需的基因,
功能,包括离子转运和突触囊泡组装和释放。我们假设,
NPC-PE可导致这些基因的异位表达,细胞周期的退出和神经元的早熟
NPC的分化。这项探索性、高风险、高回报的研究并非旨在识别所有
在整个开发过程中选择性剪接,而我们的目标是确定使用长读
测序,其中NMD被抑制以鉴定PE。此外,我们的目标是开发一种高通量的检测方法,
确定这些PE在神经发育早期阶段的作用。总的来说,这项研究的结果
将提供平台和实验范例,用于(1)鉴定用于人类的PE
神经发育(2)提供了一个框架,用于解释内含子遗传变异,
神经发育和神经精神障碍个体的基因组测序(3)确定
在发展过程中发挥这些作用。我们打算将这些数据用于未来的个人或
项目级资金申请。
英文摘要
Project summary
Exons in the genome that lead to the introduction of premature truncation (stop) codon (PTC) and mark these
transcripts as targets for nonsense-mediated decay (NMD) are called poison exons (PEs). These PEs have
recently been shown to be used throughout mouse and human neurodevelopment where they are alternatively
spliced over the course of development. Moreover, genetic variants that perturb the splicing of PEs have been
associated with neurodevelopmental disorders, including epilepsy and malformations of cortical development.
However, the full complement of PEs that are alternatively spliced throughout human development are not
known. Therefore, in Aim 1 of this study we will use long-read sequencing in induced pluripotent stem cell
(iPSC)-derived neuronal progenitor cells (NPCs) and neurons, treated with cycloheximide to inhibit NMD, to
identify PEs. Moreover, while recent efforts have elucidated the use of PEs during neurodevelopment, we have
very limited understanding of their function. In Aim 2 we will adapt the recently described paired guide RNAs
for alternative exon removal (pgFARM) approach to delete candidate PEs in iPSC-derived neuronal progenitor
cells (NPCs) and determine the effects on proliferation of these cells. Our preliminary analysis suggests that
many PEs that are included in transcripts in NPCs (NPC-PEs), encode for genes required for mature neuronal
function, including ion transport and synaptic vesicle assembly and release. We hypothesize that deletion of
NPC-PEs will lead to the ectopic expression of these genes, exit of the cell-cycle and premature neuronal
differentiation of NPCs. This exploratory, high-risk, high-reward study is not intended to identify all PEs that are
alternatively spliced throughout development, rather we aim to determine the efficacy of using long-read
sequencing where NMD is inhibited to identify PEs. Moreover, we aim to develop a high-throughput assay for
determining the role of these PEs in early stages of neurodevelopment. Collectively, the outcomes of this study
will provide the platforms and experimental paradigms for (1) identifying PEs used in human
neurodevelopment (2) provide a framework for the interpretation of intronic genetic variants identified by
genome sequencing in individuals with neurodevelopmental and neuropsychiatric disorders (3) determining the
function of these PEs in development. We intend that this data will be used to pursue future individual or
program level funding applications.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Deep mutational scanning of CHD2 for variant interpretation in neurodevelopmental disorders
-
批准号:10811491
-
项目类别:
-
资助金额:$42.08万
-
财政年份:2023
-
负责人:Gemma Louise Carvill
-
依托单位:
Gene Variant Curation Core (GVCC)
-
批准号:10455560
-
项目类别:
-
资助金额:$17.7万
-
财政年份:2020
-
负责人:Gemma Louise Carvill
-
依托单位:
Gene Variant Curation Core (GVCC)
-
批准号:10265444
-
项目类别:
-
资助金额:$18.18万
-
财政年份:2020
-
负责人:Gemma Louise Carvill
-
依托单位:
Gene Variant Curation Core (GVCC)
-
批准号:10670381
-
项目类别:
-
资助金额:$17.7万
-
财政年份:2020
-
负责人:Gemma Louise Carvill
-
依托单位:
An epigenomic approach to identifying noncoding mutations in epilepsy
-
批准号:8931100
-
项目类别:
-
资助金额:$9.11万
-
财政年份:2014
-
负责人:Gemma Louise Carvill
-
依托单位:
An epigenomic approach to identifying noncoding mutations in epilepsy
-
批准号:8804829
-
项目类别:
-
资助金额:$9.11万
-
财政年份:2014
-
负责人:Gemma Louise Carvill
-
依托单位:
海外基金